Symposia: Acute Myeloid Leukemias: Commercially Available Therapies
Program: Oral and Poster Abstracts
Type: Oral
Hematology Disease Topics & Pathways:
Acute Myeloid Malignancies, AML, Research, Clinical trials, Combination therapy, Adult, Clinical Research, Pediatric, Diseases, Treatment Considerations, Adverse Events, Myeloid Malignancies, Biological Processes, Study Population, Human, Measurable Residual Disease
Type: Oral
Hematology Disease Topics & Pathways:
Acute Myeloid Malignancies, AML, Research, Clinical trials, Combination therapy, Adult, Clinical Research, Pediatric, Diseases, Treatment Considerations, Adverse Events, Myeloid Malignancies, Biological Processes, Study Population, Human, Measurable Residual Disease
Monday, December 9, 2024: 4:30 PM-6:00 PM
Grand Hall B
(Manchester Grand Hyatt San Diego)
Moderators:
Farhad Ravandi, MBBS, University of Texas- MD Anderson Cancer Center
and
Christine M. McMahon, MD, University of Colorado School of Medicine
Disclosures:
Ravandi: Prelude: Consultancy, Honoraria, Research Funding; Astellas: Consultancy, Honoraria; Abbvie: Consultancy, Honoraria; Xencor: Research Funding; Amgen: Research Funding; Syros: Consultancy, Honoraria, Research Funding; BMS: Consultancy, Honoraria; Astyex/Taiho: Research Funding; Syndax: Honoraria.
4:30 PM
4:45 PM
5:00 PM
5:15 PM
5:30 PM
5:45 PM
See more of: Oral and Poster Abstracts
*signifies non-member of ASH